What's New for MGH Inpatient Order Entry?

 

January 15, 2012—Venous Thromboembolism (VTE) Prophylaxis

Most patients admitted to MGH must have an assessment for VTE (venous thromboembolism) documented in POE by an MD, NP, or PA. If the patient is at risk for VTE, and there is no reason not to, the provider must order prophylactic treatment. This fulfills important requirements set by the Centers for Medicare & Medicaid Services (CMS) to demonstrate meaningful use of the EHR (electronic health record). VTE is a leading cause of poor outcome for inpatient treatment, and the timely use of pharmacological and/or mechanical prophylaxis is proven to prevent VTE.

The prompt to assess the risk for VTE occurs when the provider signs orders for a patient. If indicated, one or more treatments can be ordered directly from the prompt. VTE prophylaxis can include medications recommended by the MGH Medication Education Safety & Approval Committee (MESAC), or mechanical means (pneumatic boots or TED stockings), or both. The prompt includes a link to the Anti-Coagulation Guidelines from MESAC.

The prompt takes into account whether the patient already has orders for VTE prophylaxis. Pharmacological and mechanical treatment must be considered separately. To decline either order type, you must select the reason. Each reason for declining is stored as a general care order.

Some care units, such as fetal/maternal medicine and psychiatrics, are exempt from this requirement.

Key Elements:

Instructions:

 

See also: